Breast cancer prognostication and prediction: are we making progress?

Area of Science:

• Oncology
• Genomics
• Biomarkers

Background:

• Accurate prognostic and predictive factors are vital for personalized breast cancer treatment.
• Current prognostic factors include tumor biology and stage; predictive factors identify treatment responsiveness.
• Hormone receptor status is the primary accepted predictive factor for endocrine therapy.

Purpose of the Study:

• To review recent advancements in identifying prognostic and predictive factors in breast cancer.
• To emphasize the role of gene expression profiling in understanding tumor biology and prognostication.
• To highlight the ongoing challenges in establishing reliable predictive factors for systemic therapies.

Main Methods:

• Review of current literature on breast cancer prognostication and prediction.
• Focus on findings from gene expression profiling studies.
• Analysis of established and emerging prognostic and predictive markers.

Main Results:

• Gene expression studies have enhanced understanding of breast cancer biology and prognostication.
• Lymph node status and tumor size are established prognostic factors.
• No widely accepted predictive factor for systemic therapy response, beyond hormone receptor status, has been identified.

Conclusions:

• Gene expression profiling shows promise for improving breast cancer prognostication.
• Further research is needed to identify robust predictive factors for systemic therapy.
• Personalized treatment strategies rely on the continued development of accurate prognostic and predictive markers.